PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma

Recruiting Observational Study
Pancreas Adenocarcinoma Pancreas Cancer
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
5,000 (estimated)
Sponsor
University of Ulm · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection) * Age =\>18 years * written informed consent Exclusion Criteria: * papillary cancer * neuroendocrine pancreati…
Contacts

Thomas Seufferlein, MD

+49 731 50044501

thomas.seufferlein@uniklinik-ulm.de

CONTACT